https://www.avient.com/sites/default/files/2021-12/Chemically Resistant Materials Whitepaper.pdf
In this study, Avient’s Trilliant™ HC8900 and Edgetek™
ET8900 thermoplastics were tested alongside
competitive materials used for various medical
and consumer device enclosures.
MATERIAL BRIEF DESCRIPTION
FR PC/ABS Flame retardant, chemical resistance, high ESCR
FR PC/PET Flame retardant, impact modified, chemical resistant
FR PC/PBT Skin-contact biocompatible, flame retardant, high chemical resistance
FR Copolyester Flame retardant, chemical resistant, may incorporate agency-rated materials
to meet USP Class VI or ISO 10993 requirements
Trilliant™ HC8910 Unfilled PK blend, BPA-free, high chemical resistance, may incorporate
agency-rated materials to meet USP Class VI or ISO 10993 requirements
Trilliant™ HC8920 FR Non-halogenated flame retardant PK blend, BPA-free, high chemical resistance, may
incorporate agency rated materials to meet USP Class VI or ISO 10993 requirements
Edgetek™ ET8900 CR Unfilled PK blend, high chemical resistance
Edgetek™ ET8900 HI CR High impact PK blend, high chemical resistance
Edgetek™ ET8920 FR CR Non-halogenated flame retardant PK blend, high chemical resistance
Table 2.
- -
8© 2021 Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012
Table 3B.
https://www.avient.com/investor-center/news/polyone-signs-definitive-agreement-acquire-clariant-color-and-additive-masterbatch-business
to purchase its global color and additive masterbatch business.
The company adds value to global customers and improves sustainability through formulating materials, such as:
news library online, please visit www.avient.com/news.
https://www.avient.com/sites/default/files/2022-02/MEVOPUR Bio-based Solutions Application Bulletin_JP.pdf
規制対応
評価試験:
- ISO 10993-1
- USP および (Class VI)
- 欧州薬局方 モノグラフ 3.1.3/ 3.1.5 (ポリオ
レフィン系包装材)
- USP (ポリエチレン)
- ICH Q3Dに準拠した元素不純物分析
DMF(Type III)および Device Master File 登
録済み
米国FDAおよびEUの食品接触規格
ヘルスケア用途に制限ありー下記参照詳しくはAvientにお問い合わせください。
a) 米国食品医薬品局(FDA)または国際標準化機構(ISO)により「インプラント」機器として分類される医療機器、または米国薬局方(USP)または ISO 規格で定義される「パーマネント」
機器、または
(b)EU指令90/385/EECの改正で定義された能動埋込型医療機器、または
(c)EU指令93/42/EECの改正で定義された「長期」使用のための医療機器。
この記述の一般性を制限することなく、Avient 製品は以下を目的とした医療機器用途に使用してはなりません。
https://www.avient.com/sites/default/files/2024-02/Gravi-Tech REC Recycled Formulations Product Bulletin.pdf
Avient makes no representations, guarantees, or warranties of any kind with respect to the information contained in this document about its accuracy, suitability for
particular applications, or the results obtained or obtainable using the information.
Avient makes no warranties or guarantees
respecting suitability of either Avient’s products or the information for your process or end-use application.
AVIENT MAKES NO WARRANTIES, EXPRESS OR IMPLIED,
INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, either with respect to the information or products reflected by the information.
https://www.avient.com/sites/default/files/2023-07/Avient_CodeConduct_2023_Portuguese.pdf
Specialization
Globalization
Operational
Excellence
Commercial
Excellence
Associates
3
Nosso Código de Conduta
4
Orientações para
comportamento ético
O Código de Conduta da Avient (“Código”) é um guia
para conduzir os negócios; seu objetivo é ajudar a
garantir que nossos valores sejam preservados e que a
reputação da Avient seja mantida e melhorada.
Criamos uma empresa com uma
ótima dinâmica: uma empresa com alcance global e
uma visão clara.
Como uma empresa global com sede nos Estados
Unidos, as leis dos EUA, e as leis e regulamentos de
outros países em que fazemos negócios, aplicam-se às
nossas atividades.
https://www.avient.com/sites/default/files/resources/PolyOne%25202014%2520Annual%2520Report.pdf
Exhibit 31.1
CERTIFICATION
I, Robert M.
Patterson
Exhibit 31.2
CERTIFICATION
I, Bradley C.
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C.
https://www.avient.com/sites/default/files/2024-10/Avient_CodeConduct_2024_PORT2.pdf
Criamos uma empresa com uma ótima dinâmica: uma empresa
com alcance global e uma visão clara.
Leia nossa Política Global de Despesas de Negócios
disponível no The Loop, em Pessoas e departamentos, Ética e
políticas corporativas.
Consulte a Política Global Antissuborno
e Anticorrupção da Avient e a Política de Presentes e Entretenimento
disponível em The Loop – Pessoas e departamentos – Ética e políticas
corporativas.
https://www.avient.com/investor-center/news/avient-announces-fourth-quarter-and-full-year-2022-results
to Work® certification, achieving the highest employee engagement scores in the history of the company
That being said, versus the prior year, global demand conditions and inventory destocking negatively impacted nearly every industry and region during the quarter,"
news library online, please visit www.avient.com/news.
https://www.avient.com/sites/default/files/2021-12/AVNT 2021 Investor Day_0.pdf
These
investments also consider our global footprint, and we are
positioned very well and strategically from a regional perspective.
Avient Corporation 25
UN Global Compact Commitment
Sustainability Report
Continuous ESG Improvement
• Updated 2030 Sustainability Goals
• Further disclosure on key Environmental,
Social, and Governance impacts
• Joined U.N.
Global Compact and identified
alignment with U.N.
https://www.avient.com/investor-center/news/polyone-shareholders-approve-all-proposals-2016-annual-meeting-robert-m-patterson-becomes-chairman-board
NYSE: POL), a leading global provider of specialized polymer materials, services and solutions, today held its 2016 annual meeting of shareholders, during which time all presented proposals before shareholders were approved.
news library online, please visit www.avient.com/news
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: our ability to realize anticipated savings and operational benefits from the realignment of assets, including the closure of manufacturing facilities; the timing of closings and shifts of production to new facilities related to asset realignments and any unforeseen loss of customers and/or disruptions of service or quality caused by such closings and/or production shifts; separation and severance amounts that differ from original estimates; amounts for non-cash charges related to asset write-offs and accelerated depreciation realignments of property, plant and equipment, that differ from original estimates; our ability to identify and evaluate acquisition targets and consummate acquisitions; the ability to successfully integrate acquired businesses into our operations, including whether such businesses will be accretive to our earnings, retain the management teams of acquired businesses, and retain relationships with customers of acquired businesses; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability; the speed and extent of an economic recovery, including the recovery of the housing market; our ability to achieve new business gains; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding the disposal of plastic in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions and employee productivity goals; an inability to raise or sustain prices for products or services; an inability to maintain appropriate relations with unions and employees; our ability to continue to pay cash dividends; the amount and timing of repurchases of our common shares, if any; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.